Breno S. Diniz

13.3k total citations · 3 hit papers
172 papers, 8.8k citations indexed

About

Breno S. Diniz is a scholar working on Psychiatry and Mental health, Physiology and Biological Psychiatry. According to data from OpenAlex, Breno S. Diniz has authored 172 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Psychiatry and Mental health, 61 papers in Physiology and 38 papers in Biological Psychiatry. Recurrent topics in Breno S. Diniz's work include Dementia and Cognitive Impairment Research (56 papers), Tryptophan and brain disorders (38 papers) and Alzheimer's disease research and treatments (37 papers). Breno S. Diniz is often cited by papers focused on Dementia and Cognitive Impairment Research (56 papers), Tryptophan and brain disorders (38 papers) and Alzheimer's disease research and treatments (37 papers). Breno S. Diniz collaborates with scholars based in Brazil, United States and Canada. Breno S. Diniz's co-authors include Orestes Vicente Forlenza, Wagner F. Gattaz, Antônio Lúcio Teixeira, Leda Leme Talib, Charles F. Reynolds, Meryl A. Butters, Jerzy Leszek, Vanessa de Jesus Rodrigues de Paula, Marta Sochocka and Márcia Radanovic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Breno S. Diniz

170 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies

2013 916 citations Breno S. Diniz, Meryl A. Butters et al. profile →
The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review

2018 432 citations Breno S. Diniz et al. profile →
Plasma Biomarkers of Alzheimer’s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice

2023 73 citations Marcos Vasconcelos Pais, Orestes Vicente Forlenza et al. Journal of Alzheimer s Disease Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Breno S. Diniz Brazil	52	3.1k	2.8k	1.5k	1.3k	1.2k	172	8.8k
Orestes Vicente Forlenza Brazil	53	3.7k 1.2×	2.9k 1.0×	1.7k 1.1×	778 0.6×	1.4k 1.2×	288	9.3k
Peter P. Zandi United States	55	3.7k 1.2×	3.0k 1.1×	1.6k 1.1×	788 0.6×	1.1k 0.9×	202	11.4k
Sanjay Asthana United States	62	3.3k 1.1×	4.8k 1.7×	2.9k 1.9×	1.1k 0.8×	1.5k 1.2×	293	12.0k
Steen Gregers Hasselbalch Denmark	47	2.2k 0.7×	2.8k 1.0×	1.9k 1.2×	539 0.4×	1.0k 0.8×	203	8.9k
Cynthia M. Carlsson United States	54	2.7k 0.9×	3.7k 1.3×	2.4k 1.6×	1.0k 0.7×	1.3k 1.0×	217	9.2k
Willem A. van Gool Netherlands	58	3.1k 1.0×	3.0k 1.1×	1.5k 1.0×	611 0.5×	2.6k 2.1×	235	12.3k
Barbara B. Bendlin United States	54	2.7k 0.9×	4.1k 1.5×	2.4k 1.6×	1.1k 0.8×	1.5k 1.2×	271	10.1k
Robert K. McNamara United States	49	1.6k 0.5×	1.8k 0.6×	1.6k 1.1×	1.0k 0.8×	1.0k 0.8×	180	8.6k
Gianfranco Spalletta Italy	58	3.5k 1.1×	1.6k 0.6×	1.2k 0.8×	919 0.7×	1.4k 1.1×	269	11.3k
Owen M. Wolkowitz United States	64	1.8k 0.6×	3.4k 1.2×	1.8k 1.2×	2.9k 2.2×	585 0.5×	223	13.9k

Countries citing papers authored by Breno S. Diniz

Since Specialization

Citations

This map shows the geographic impact of Breno S. Diniz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Breno S. Diniz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Breno S. Diniz more than expected).

Fields of papers citing papers by Breno S. Diniz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Breno S. Diniz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Breno S. Diniz. The network helps show where Breno S. Diniz may publish in the future.

Co-authorship network of co-authors of Breno S. Diniz

This figure shows the co-authorship network connecting the top 25 collaborators of Breno S. Diniz. A scholar is included among the top collaborators of Breno S. Diniz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Breno S. Diniz. Breno S. Diniz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuo, Chia‐Ling, Eero Vuoksimaa, Jaakko Kaprio, et al.. (2025). A proteomic signature of healthspan. Proceedings of the National Academy of Sciences. 122(23). e2414086122–e2414086122. 4 indexed citations

Xue, Xiangning, Eric J. Lenze, Charles F. Reynolds, et al.. (2024). Sex differences in plasma proteomic markers in late-life depression. Psychiatry Research. 334. 115773–115773. 5 indexed citations

Kuo, Chia‐Ling, Luke C. Pilling, Janice L. Atkins, et al.. (2024). Proteomic aging clock ( PAC ) predicts age‐related outcomes in middle‐aged and older adults. Aging Cell. 23(8). e14195–e14195. 18 indexed citations

Jia, Zhengyang, et al.. (2023). CRISPR-Powered Aptasensor for Diagnostics of Alzheimer’s Disease. ACS Sensors. 9(1). 398–405. 18 indexed citations

Pais, Marcos Vasconcelos, Orestes Vicente Forlenza, & Breno S. Diniz. (2023). Plasma Biomarkers of Alzheimer’s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice. Journal of Alzheimer s Disease Reports. 7(1). 355–380. 73 indexed citations breakdown →

Kuchel, George A., et al.. (2022). Major depression and the biological hallmarks of aging. Ageing Research Reviews. 83. 101805–101805. 71 indexed citations

Mendes‐Silva, Ana Paula, Patrícia Tiemi Fujimura, Antônio Lúcio Teixeira, et al.. (2019). Brain-enriched MicroRNA-184 is downregulated in older adults with major depressive disorder: A translational study. Journal of Psychiatric Research. 111. 110–120. 27 indexed citations

Diniz, Breno S., et al.. (2018). ACNP 57th Annual Meeting: Poster Session III. Neuropsychopharmacology. 43(S1). 383–527. 3 indexed citations

Wu, Hanjing Emily, Antônio Lúcio Teixeira, Ana Paula Mendes‐Silva, et al.. (2018). Epidermal growth factor and fibroblast growth factor-2 circulating levels in elderly with major depressive disorder. Psychiatry Research. 272. 141–143. 14 indexed citations

10.

Costa, Mônica Vieira, et al.. (2016). Accuracy of three depression screening scales to diagnose major depressive episodes in older adults without neurocognitive disorders. Brazilian Journal of Psychiatry. 38(2). 154–156. 36 indexed citations

11.

Malloy‐Diniz, Leandro Fernandes, et al.. (2015). Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis. Journal of Psychiatric Research. 69. 35–41. 58 indexed citations

12.

Diniz, Breno S., Antônio Lúcio Teixeira, Rodrigo Machado‐Vieira, et al.. (2014). Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression. The Journals of Gerontology Series B. 69(6). 845–851. 52 indexed citations

13.

Diniz, Breno S., Antônio Lúcio Teixeira, Rodrigo Machado‐Vieira, et al.. (2013). Reduced Serum Nerve Growth Factor in Patients With Late-Life Depression. American Journal of Geriatric Psychiatry. 21(5). 493–496. 53 indexed citations

14.

Paula, Jonas Jardim de, Laiss Bertola, Gabriel Coutinho, et al.. (2013). Correction: Clinical Applicability and Cutoff Values for an Unstructured Neuropsychological Assessment Protocol for Older Adults with Low Formal Education. PLoS ONE. 8(10). 7 indexed citations

15.

Joaquim, Helena Passarelli Giroud, Leda Leme Talib, Orestes Vicente Forlenza, Breno S. Diniz, & Wagner F. Gattaz. (2012). Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. Journal of Psychiatric Research. 46(8). 1053–1058. 23 indexed citations

16.

Diniz, Breno S., Antônio Lúcio Teixeira, Alline C. Campos, et al.. (2012). Reduced serum levels of adiponectin in elderly patients with major depression. Journal of Psychiatric Research. 46(8). 1081–1085. 79 indexed citations

17.

Diniz, Breno S., Antônio Lúcio Teixeira, Aline Silva de Miranda, et al.. (2011). Circulating Glial-derived neurotrophic factor is reduced in late-life depression. Journal of Psychiatric Research. 46(1). 135–139. 52 indexed citations

18.

Teixeira, Antônio Lúcio, Izabela Guimarães Barbosa, Breno S. Diniz, & Arthur Kümmer. (2010). Circulating Levels of Brain-Derived Neurotrophic Factor: Correlation with mood, Cognition and Motor Function. Biomarkers in Medicine. 4(6). 871–887. 135 indexed citations

19.

Forlenza, Orestes Vicente, Breno S. Diniz, Leda Leme Talib, et al.. (2009). Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. 28(6). 507–512. 184 indexed citations

20.

Diniz, Breno S. & Almir Tavares. (2001). As bases biologicas da doenca de Alzheimer. 11(2). 92–97. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact